Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 1;70(15):6277-82.
doi: 10.1158/0008-5472.CAN-09-4224. Epub 2010 Jul 7.

Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors

Affiliations

Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors

Elena V Efimova et al. Cancer Res. .

Abstract

Persistent DNA double-strand breaks (DSB) may determine the antitumor effects of ionizing radiation (IR) by inducing apoptosis, necrosis, mitotic catastrophe, or permanent growth arrest. IR induces rapid modification of megabase chromatin domains surrounding DSBs via poly-ADP-ribosylation, phosphorylation, acetylation, and protein assembly. The dynamics of these IR-induced foci (IRIF) have been implicated in DNA damage signaling and DNA repair. As an IRIF reporter, we tracked the relocalization of green fluorescent protein fused to a chromatin binding domain of the checkpoint adapter protein 53BP1 after IR of breast cancer cells and tumors. To block DSB repair in breast cancer cells and tumors, we targeted poly(ADP-ribose) polymerase (PARP) with ABT-888 (veliparib), one of several PARP inhibitors currently in clinical trials. PARP inhibition markedly enhanced IRIF persistence and increased breast cancer cell senescence both in vitro and in vivo, arguing for targeting IRIF resolution as a novel therapeutic strategy.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest are known.

Figures

Figure 1
Figure 1
GFP-IBD reporter reveals IRIF formation and kinetics. A, shRNA knockdown of the upstream DNA damage response protein ATM, MDC1 or RNF8 abrogates GFP-IBD reporter relocalization to IRIF. shRNA knockdown of endogenous 53BP1 increases foci numbers at 3 and 24 h. Scale bar, 10 μm. B, Formation and resolution of GFP-IBD foci in response to IR depend on time and dose. Scale bar, 10 μm. C, Mean number of GFP-IBD foci per cell ± SD (n > 50) at increasing IR doses evaluated at 3 h (solid circles) and 24 h (solid squares). D, Clonogenic survival of MCF7Tet-On GFP-IBD cells treated with increasing doses of IR (means ± SD, n = 3). Clonogenicity is modeled as distinct regimes of lower lethality from 0 to 6 Gy (% survival = 330 × e−0.89 x (dose in Gy), R2 = 0.958) and higher lethality from 6 to 12 Gy (% survival = 20.0 × e−1.99 x (dose in Gy), R2 = 0.999). Clonogenic efficiency of untreated MCF7Tet-On GFP-IBD cells represents 100% control.
Figure 2
Figure 2
PARP1 inhibitor ABT-888 (veliparib) alters IRIF dynamics and suppresses cell proliferation. A, ABT-888 increased the number of residual IRIF 24 h after IR. Cells were pretreated with DMSO (control) or 10 μM ABT-888 (inset) for 30 min before IR. Live cell images shown at 3 h and 24 h. Scale bar, 5 μm. B, Immunofluorescence reveals co-localization of GFP-IBD with γH2AX, MDC1, and endogenous, full-length 53BP1 at IRIF in cells treated with 6 Gy ± ABT-888. Nuclei indicated by DAPI staining (blue). Scale bar, 10 μm. C, Time-lapse live cell imaging of GFP-IBD localization in MCF7Tet-On GFP-IBD cells treated with 6 Gy ± ABT-888. Scale bar, 10 μm. D, ABT-888 suppresses cell growth of irradiated MCF7Tet-On GFP-IBD cells. Cells were treated as shown, fixed at 10 d and stained with crystal violet.
Figure 3
Figure 3
ABT-888 induces accelerated senescence in irradiated MCF7Tet-On GFP-IBD cells. A, MCF7Tet-On GFP-IBD cells treated with IR + ABT-888 display persistent IRIF and develop senescent morphology. Scale bar, 20 μm. B, IR + ABT-888 increases SA-βGal activity. Cells were treated with 6 Gy ± ABT-888, fixed at 7 d and stained. Scale bar, 20 μm. C, Relative p21Cip1/WAF1 transcript levels after IR ± ABT-888 determined by qPCR (mean ± SD, IR, white bars; IR + ABT-888, grey bars). D, Immunofluorescence staining for p21Cip1/WAF1 at 4 d after 3 Gy ± ABT-888. Scale bar, 20 μm.
Figure 4
Figure 4
IR + ABT-888 induces persistent IRIF and senescence in vivo and suppresses MCF7Tet-On GFP-IBD tumor regrowth. A, Dose-response of IRIF formation in xenograft tumor cells 24 h after IR. Scale bar, 10 μm. B, IR + ABT-888 increases residual IRIF compared to IR alone. Intravital imaging of GFP-IBD foci in tumors at 3 and 24 h after 3 Gy ± ABT-888. Scale bar, 10 μm. C, SA-βGal activity in tumors treated with IR ± ABT-888. Frozen sections of excised tumors 7 d after IR were fixed and stained. Scale bar, 20 μm. D, ABT-888 + IR suppresses tumor regrowth. Tumor growth was significantly delayed after 6 Gy + ABT-888 (solid squares) compared to 6 Gy (solid circles). Data graphed as mean fractional volume (V/Vo) ± SEM (n = 4/group).

References

    1. Ljungman M. Targeting the DNA damage response in cancer. Chem Rev. 2009;109:2929. - PubMed
    1. Schreiber V, Dantzer F, Ame JC, de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 2006;7:517–28. - PubMed
    1. Gagne JP, Isabelle M, Lo KS, et al. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res. 2008;36:6959–76. - PMC - PubMed
    1. Kraus WL. New functions for an ancient domain. Nat Struct Mol Biol. 2009;16:904–7. - PubMed
    1. Rodon J, Iniesta MD, Papadopoulos K. Development of PARP inhibitors in oncology. Expert Opin Investig Drugs. 2009;18:31–43. - PubMed

Publication types

MeSH terms

Substances